The civic record
Read. Follow. Verify.Saving Access to Laboratory Services Act (H.R. 2377)
Record date · December 17, 2024
Track this bill to get notified when it advances a stage. One tap to stop, anytime.
What This Bill Would Do
This bill changes how Medicare calculates payments for clinical laboratory tests to reduce the reporting burden on labs and adjust payment rate limits. It introduces a statistical sampling method for widely available tests and modifies the schedule for reporting private-payor data to Medicare.
The bill alters the financial reimbursement rates for clinical laboratories serving Medicare patients, which directly impacts the operational costs for hospitals, independent labs, and physician offices, and changes the frequency and method by which these entities must report data to the federal government.
Who It Would Affect
Groups the bill's text would affect if enacted, as described in the record. Being affected is not a position for or against it.
Clinical laboratories
These entities must comply with new statistical sampling requirements and updated data reporting timelines.
Medicare beneficiaries
The bill impacts the payment rates for laboratory services, which may influence the availability or cost of diagnostic testing under Medicare.
Centers for Medicare & Medicaid Services
The agency is tasked with developing new sampling methodologies and implementing the bill's provisions through rulemaking.
Key Facts
You don't have to trust us. Each fact below is taken straight from the official document - click any one to see the exact passage, highlighted in the original.
Frequently Asked Questions
How does this bill change how often labs report data?
What is a 'widely available' clinical diagnostic laboratory test?
Will my Medicare lab test costs change?
What else do you want to know?
News Coverage
Follow the record
Votes, people, money & the original sourceWhere This Stands
Currently filed. The next step in the legislative lifecycle is Committee.
Version history
Only one version on file - nothing to compare yet. As later stages (committee substitute, engrossed, enrolled) are captured, the redline appears here.
View official text →Full breakdown
Who this bill affects and the strongest case for and against it, written only from the bill’s own text.
Discoveries
Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.
Shift to Statistical Sampling
The bill moves away from universal data reporting for common lab tests toward a statistical sampling model, indicating a policy shift to reduce administrative burden.
Connected Entities
Sources
www.congress.gov
Analysis Score
0–100- Significance75How much this matters to a regular citizen
- Controversy20Intensity of disagreement among stakeholders
- Entertainment5Compellingness for a non-policy-wonk reader
- Buzz15Current news / social attention level
Publisher tools
